To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Platelet-Rich Plasma and Bone Marrow Aspirate Concentrate for Tibial Fractures

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
October 2022

Platelet-Rich Plasma and Bone Marrow Aspirate Concentrate for Tibial Fractures

Study Type:Randomized Trial
OE Level Evidence:N/A
Journal Level of Evidence:N/A

Tibial Fracture - Platelet-Rich Plasma and Bone Marrow Aspirate Concentrate (T-PAC): A Randomized Controlled Feasibility Study

Contributing Authors:
J Vun M Panteli P Harwood A Howard N Kanakaris J El-Jawhari E Jones P Giannoudis

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

CONFERENCE ACE REPORTS

This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.

Synopsis

Forty-five patients with unilateral closed tibial diaphyseal fractures were randomized to receive either platelet-rich plasma (PRP) and bone marrow aspirate concentrate (BMAC) with standard care or standard care alone. Primary outcomes of interest were time to painless weight bearing, radiological union (2, 8, 12, 16, 20, 26, and 39 weeks), and patient-reported outcome measures (0, 12, 26, and 39 ...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.